KOZARICH JOHN W sold 1.0% of their position (467.00 shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $83.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 10/3/2025ACC: 0002001011-25-000093
-467.00
Net shares
Net seller
$83.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
467.00 disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−24.00
Price / share
$177.60
Trade value
$4.26K
% of position
0.1%
10/1/2025
45.52K→45.50K
Common Stock
Direct
Shares
−196.00
Price / share
$178.41
Trade value
$34.97K
% of position
0.4%
10/1/2025
45.50K→45.30K
Common Stock
Direct
Shares
−155.00
Price / share
$180.01
Trade value
$27.90K
% of position
0.3%
10/1/2025
45.30K→45.15K
Common Stock
Direct
Shares
−92.00
Price / share
$181.18
Trade value
$16.67K
% of position
0.2%
10/1/2025
45.15K→45.05K
Total
Net shares
−467.00
Net value
-$83.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2025 | S · Sale | −24.00 | $177.60 | $4.26K | 0.1% | 45.52K | 45.50K |
| Common Stock Direct | 10/1/2025 | S · Sale | −196.00 | $178.41 | $34.97K | 0.4% | 45.50K | 45.30K |
| Common Stock Direct | 10/1/2025 | S · Sale | −155.00 | $180.01 | $27.90K | 0.3% | 45.30K | 45.15K |
| Common Stock Direct | 10/1/2025 | S · Sale | −92.00 | $181.18 | $16.67K | 0.2% | 45.15K | 45.05K |
| Total | −467.00 | -$83.80K | ||||||
Derivative Transactions0
No derivative transactions reported